Table 3.
Adjusted odds ratios (95% CI) of management procedures and outcomes associated with critically ill patients with acute kidney injury
| No. of patients | No. of AKI patients | Crude odds ratio (95% CI) | p valuea | Adjusted odds ratio (95% CI) | p valuea | |
|---|---|---|---|---|---|---|
| In-hospital mortality | 203,373 | 51,823 | 6.33 (6.25–6.42) | < 0.001 | 3.74 (3.68–3.79) | < 0.001 |
| Mechanical ventilation | 371,592 | 67,916 | 4.72 (4.66–4.77) | < 0.001 | 2.87 (2.83–2.91) | < 0.001 |
| ECMO | 4618 | 2559 | 16.18 (15.24–17.17) | < 0.001 | 6.99 (6.53–7.19) | < 0.001 |
| Vasopressor drugs | 181,936 | 40,523 | 4.71 (4.64–4.77) | < 0.001 | 2.75 (2.71–2.79) | < 0.001 |
Adjusted for age, gender, tertiary hospital, year, Charlson index, myocardial infarction, congestive heart failure, cerebrovascular disease, rheumatologic disease, peptic ulcer disease, liver disease, diabetes, renal disease, cancer, AIDS/HIV, and organ dysfunction (respiratory, cardiovascular, hepatic, hematologic, neurologic)
AIDS acquired immune deficiency syndrome, AKI acute kidney injury, CI confidence interval, ECMO extracorporeal membrane oxygenation, HIV human immunodeficiency virus
aMixed effects logistic regression model